Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders

We prospectively studied 50 patients treated with interferon-α for chronic hepatitis and found no evidence that patients with a pre-existing mood or anxiety disorder were more likely than other patients to interrupt the interferon-α therapy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1999-07, Vol.354 (9173), p.131-132
Hauptverfasser:	Pariante, Carmine M, Orrù, M Germana, Baita, Antonella, Farci, M Giulia, Carpiniello, Bernardo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Case-Control Studies Female Hepatitis B, Chronic - psychology Hepatitis B, Chronic - therapy Hepatitis C, Chronic - psychology Hepatitis C, Chronic - therapy Humans Immunomodulators Interferon-alpha - therapeutic use Male Medical sciences Mood Disorders - complications Patient Compliance Pharmacology. Drug treatments Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We prospectively studied 50 patients treated with interferon-α for chronic hepatitis and found no evidence that patients with a pre-existing mood or anxiety disorder were more likely than other patients to interrupt the interferon-α therapy.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(98)04793-X